Rapid streptococcal testing for sore throat and antibiotic resistance

  • Sheeler R
  • Little P
  • 14


    Mendeley users who have this article in their library.
  • 8


    Citations of this article.


This article briefly summarises the arguments for and against the routine use of rapid antigen testing for group A β-haemolytic streptococcal pharyngitis and the deficiencies in the current evidence base in this area. Currently, most commercial tests are immunoassays with a sensitivity of 70-955% (average 85%) and a specificity of 95-99%, depending on the comparator and patient population. Rapid antigen testing is recommended and commonly used in the USA, especially for patients in whom group A β-haemolytic streptococcal infection is clinically likely or who have any symptoms plus direct contact exposure. However, there is no consensus in Europe regarding the role of rapid testing. There remains a need for randomised trials to evaluate its benefit to patients and its cost-effectiveness compared with the main alternatives, including delayed antibiotic prescribing. © 2006 European Society of Clinical Microbiology and Infectious Diseases.

Author-supplied keywords

  • Group A β-haemolytic streptococcus
  • Pharyngitis
  • Rapid antigen testing

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Robert D. Sheeler

  • P. Little

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free